HOSPITAL REPORT
|
As healthcare facilities across the nation deal with shortages of certain drugs, including generics, pharmacists and pharmacy managers are tasked with the daily monitoring of drug supplies and increased communications with other healthcare professionals. More |
|
FDA
FDA has approved cholic acid (Cholbam), a once-daily treatment for pediatric and adult patients who have bile acid synthesis disorders due to single enzyme defects. More |
EDITOR'S CHOICE
Lemtrada (alemtuzumab) received FDA approval on November 14, 2014, under fast track designation, for the treatment of patients with relapsing forms of MS. More |
Inside The Latest Issue
|
|
|
